Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$GILD Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$8.45 down -638.22% YoY • Reported revenue of $7.8B up 10.18% YoY • Gilead Sciences, Inc. now expects full year 2026 product sales between $30.1 billion and $30.4 billion, with diluted loss per share between $(3.75) and $(3.40) and non-GAAP diluted loss per share between $(0.65) and $(0.30).
1

Price since post

Full Details

Advertisement|Remove ads.